CS
GOCO

Candriam SCA’s GoHealth GOCO Stock Holding History

Candriam SCA’s Portfolio GOCO Stock Details GOCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-10,806
Closed -$113K – 899
2022
Q4 		$113K Buy
+10,806
New +$95.9K ﹤0.01% 858

Other funds holding GOCO

CP
Centerbridge Partners New York $61.1M AUM 3.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
GCM
Glendon Capital Management Santa Monica, California $805M AUM 17.91% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Candriam SCA's GOCO Position: Q1 2023 in Review

Candriam SCA sold out of GoHealth (GOCO) in Q1 2023, closing a stake of 10,806 shares — an estimated $113K sold.

Candriam SCA first reported a position in GOCO in Q4 2022 and held it in 1 quarter. The position peaked at $113K in Q4 2022. 32 funds tracked by Wall St. Rank hold GOCO as of Q1 2023.

  • Candriam SCA reported no remaining GoHealth position as of Q1 2023 after selling out during the quarter.
  • Candriam SCA sold 10,806 GoHealth shares in Q1 2023, an estimated $113K.
  • Candriam SCA first reported a position in GoHealth in Q4 2022 and held it in 1 quarter.
  • Candriam SCA's GoHealth position peaked at $113K in Q4 2022.
  • 32 funds tracked by Wall St. Rank held GoHealth as of Q1 2023.

Based on Candriam SCA's 13F filing for Q1 2023, filed 12 May 2023.